The report will be delivered in 2-3 business days.

Regenerative Medicine For Cartilage Global Market Report 2021: COVID-19 Growth And Change

aboutimg
Purchase Options
Request Sample
Request For Discount

Starting Price : $5000.00 | Pages : 150 | Published : March 2021 | SKU CODE : h036 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The regenerative medicine for cartilage market consists of sales of regenerative medicines for the cartilage by entities (organizations, sole traders, and partnerships) that have the capacity to grow muscles and organs in the lab and safely implant them when the body cannot regenerate itself, as observed for cartilage tissue after injury or wear. Only goods and services traded between entities or sold to end consumers are included.

The main types of regenerative medicine for cartilage are cell-based and non-cell-based. The type of treatment includes palliative and intrinsic repair stimulus among others that are used by ambulatory surgical centers, hospitals and clinics, and surgical centers. The regenerative medicine for cartilage is used for hyaline cartilage repair and regeneration, elastic cartilage repair and regeneration, and fibrous cartilage repair and regeneration.

The global regenerative medicine for cartilage market is expected to grow from $4.47 billion in 2020 to $4.83 billion in 2021 at a compound annual growth rate (CAGR) of 8.10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.56 billion in 2025 at a CAGR of 7.94%.

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.

Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.

In April 2019, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew’s advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.

Major players in the regenerative medicine for cartilage market  are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes.

Europe was the largest region in regenerative medicine for cartilage in 2020. The regions covered in the regenerative medicine for cartilage market  report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the regenerative medicine for cartilage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global regenerative medicine for cartilage market is segmented -

1) By Treatment Modality: Cell-Based, Non-Cell-Based

2) By Treatment Type: Palliative, Intrinsic Repair Stimulus, Others

3) By Site: Knee Cartilage Repair, Ribs, Others

4) By Application: Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration

5) By End-Use: Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, Others

    Table Of Contents

    1. Executive Summary

    2. Regenerative Medicine For Cartilage

    Market Characteristics

    3. Regenerative Medicine For Cartilage

    Market Trends And Strategies

    4. Impact Of COVID-19 On Regenerative Medicine For Cartilage

    5. Regenerative Medicine For Cartilage

    Market Size And Growth

    5.1. Global Regenerative Medicine For Cartilage

    Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Regenerative Medicine For Cartilage

    Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Regenerative Medicine For Cartilage

    Market Segmentation

    6.1. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cell-Based

    Non-Cell-Based

    6.2. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Palliative

    Intrinsic Repair Stimulus

    Others

    6.3. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Site, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Knee Cartilage Repair

    Ribs

    Others

    6.4. Global Regenerative Medicine For Cartilage

    Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hyaline Cartilage Repair and Regeneration

    Elastic Cartilage Repair and Regeneration

    Fibrous Cartilage Repair and Regeneration

    6.5. Global Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Ambulatory Surgical Centers

    Hospitals & Clinics

    Surgical Centers

    Others

    7. Regenerative Medicine For Cartilage

    Market Regional And Country Analysis

    7.1. Global Regenerative Medicine For Cartilage

    Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Regenerative Medicine For Cartilage

    Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Regenerative Medicine For Cartilage

    Market

    8.1. Asia-Pacific Regenerative Medicine For Cartilage

    Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Regenerative Medicine For Cartilage

    Market

    9.1. China Regenerative Medicine For Cartilage

    Market Overview

    9.2. China Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Regenerative Medicine For Cartilage

    Market

    10.1. India Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Regenerative Medicine For Cartilage

    Market

    11.1. Japan Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Regenerative Medicine For Cartilage

    Market

    12.1. Australia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Regenerative Medicine For Cartilage

    Market

    13.1. Indonesia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Regenerative Medicine For Cartilage

    Market

    14.1. South Korea Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Regenerative Medicine For Cartilage

    Market

    15.1. Western Europe Regenerative Medicine For Cartilage

    Market Overview

    15.2. Western Europe Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Regenerative Medicine For Cartilage

    Market

    16.1. UK Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Regenerative Medicine For Cartilage

    Market

    17.1. Germany Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Regenerative Medicine For Cartilage

    Market

    18.4. France Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Regenerative Medicine For Cartilage

    Market

    19.1. Eastern Europe Regenerative Medicine For Cartilage

    Market Overview

    19.2. Eastern Europe Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Regenerative Medicine For Cartilage

    Market

    20.1. Russia Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Regenerative Medicine For Cartilage

    Market

    21.1. North America Regenerative Medicine For Cartilage

    Market Overview

    21.2. North America Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Regenerative Medicine For Cartilage

    Market

    22.1. USA Regenerative Medicine For Cartilage

    Market Overview

    22.2. USA Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Regenerative Medicine For Cartilage

    Market

    23.1. South America Regenerative Medicine For Cartilage

    Market Overview

    23.2. South America Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Regenerative Medicine For Cartilage

    Market

    24.1. Brazil Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Regenerative Medicine For Cartilage

    Market

    25.1. Middle East Regenerative Medicine For Cartilage

    Market Overview

    25.2. Middle East Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Regenerative Medicine For Cartilage

    Market

    26.1. Africa Regenerative Medicine For Cartilage

    Market Overview

    26.2. Africa Regenerative Medicine For Cartilage

    Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Regenerative Medicine For Cartilage

    Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Regenerative Medicine For Cartilage

    Market Competitive Landscape And Company Profiles

    27.1. Regenerative Medicine For Cartilage

    Market Competitive Landscape

    27.2. Regenerative Medicine For Cartilage

    Market Company Profiles

    27.2.1. B. Braun Melsungen AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Zimmer Biomet Holdings Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Vericel Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Stryker Corporation

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Smith & Nephew plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage

    Market

    29. Regenerative Medicine For Cartilage

    Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Site, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Regenerative Medicine For Cartilage
  • Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Regenerative Medicine For Cartilage
  • Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 48: B. Braun Melsungen AG Financial Performance
  • Table 49: Zimmer Biomet Holdings Inc. Financial Performance
  • Table 50: Vericel Corporation Financial Performance
  • Table 51: Stryker Corporation Financial Performance
  • Table 52: Smith & Nephew plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Modality, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Site, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Regenerative Medicine For Cartilage
  • Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Regenerative Medicine For Cartilage
  • Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: China, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: India, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Japan, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Australia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: Indonesia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South Korea, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Western Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: UK, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: Germany, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: France, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Eastern Europe, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: Russia, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: North America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: USA, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: South America, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Brazil, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Middle East, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By Treatment Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: Africa, Regenerative Medicine For Cartilage
  • Market, Segmentation By End-Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 48: B. Braun Melsungen AG Financial Performance
  • Figure 49: Zimmer Biomet Holdings Inc. Financial Performance
  • Figure 50: Vericel Corporation Financial Performance
  • Figure 51: Stryker Corporation Financial Performance
  • Figure 52: Smith & Nephew plc Financial Performance
Global Prostate Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pegfilgrastim Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical API Manufacturing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Excipients Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Sterility Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pediatric Vaccine Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Craniomaxillofacial (CMF) Devices And Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Hearing Implants Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Orthobiologics Devices And Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)